Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2011 / Cilt: 25 - Sayı: 2

Inefficacy of dapson treatment in a patient with erythema dyschromicum perstans

Dapson tedavisine yanıtsız bir eritema diskromikum perstans olgusu

Pages
107–111
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we report a 36-year-old male of EDP who did not response to dapson treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Erythema dyschromicum perstans is an uncommon, benign, chronic, idiopathic pigmentary disorder characterized by asymptomatic, slowly progressive, ashy-gray macules over the trunk, extremities, face and neck with symmetrical distribution.
📊
Key Findings & Data:No consistently effective treatment is yet available for this disease.
💡
Conclusion & Impact:Herein, we report a 36-year-old male of EDP who did not response to dapson treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Erythema dyschromicum perstans is an uncommon, benign, chronic, idiopathic pigmentary disorder characterized by asymptomatic, slowly progressive, ashy-gray macules over the trunk, extremities, face and neck with symmetrical distribution. No consistently effective treatment is yet available for this disease. Many therapeutic options have been tried, but the majority of them have been ineffective except clofazimine and dapson. Herein, we report a 36-year-old male of EDP who did not response to dapson treatment.

Özet

Eritema diskromikum perstans gövde, ekstremiteler, yüz ve boyunda simetrik dağılım gösteren, asemptomatik ve yavaş ilerleyen kül grisi renginde maküllerle karakterize nadir görülen, benign, kronik ve idiyopatik bir pigmentasyon bozukluğudur. Bu hastalıkta tamamen etkili olan bir tedavi seçeneği henüz mevcut değildir. Birçok tedavi seçeneğinin denendiği görülmüş, ancak klofazimin ve dapson dışındaki tedavilerin büyük çoğunluğunun etkisiz olduğu bildirilmiştir. Burada dapson tedavisine yanıtsız EDP’lu 36 yaşında bir erkek olgu sunulmaktadır.

🔖

Cite This Article

AKARSU, S., İLKNUR, T., YILMAZ, Y., LEBE, B., FETİL, E. (2011). Inefficacy of dapson treatment in a patient with erythema dyschromicum perstans. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 25 - Sayı: 2, 107–111. https://ajindex.com/articles/188811

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Knox JM, Dodge BG, Freeman RG. Erythema dyschromicum perstans. Arch Dermatol 1968;97:262-272
  2. Schwartz RA. Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis. Int J Dermatol 2004;43:230-232
  3. Karaarslan IK, Türkmen M, Kandiloğlu G, Kazandı AC, Alper S. Erythema dyschromicum perstans: a case report (Bir eritema diskromikum perstans olgusu). Turkiye Klinikleri J Dermatol 2008;18:199-202
  4. Osswald SS, Proffer LH, Sartori CR. Erythema dyschromicum perstans: a case report and review. Cutis 2001;68:25-28
  5. Silverberg NB, Herz J, Wagner A, Paller AS. Erythema dyschromicum perstans in prepubertal children. Pediatr Dermatol 2003;20:398-403
  6. Baranda L, Torres-Alvarez B, Cortes-Franco R, Moncada B, Portales-Perez DP, Gonzalez-Amaro R. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy. Arch Dermatol 1997;133:325-329
  7. Kontochristopoulos G, Stavropoulos P, Panteleos D, Aroni K. Erythema dyschromicum perstans: response to dapsone therapy. Int J Dermatol 1998;37:796-798
  8. Bahadır S, Çobanoglu U, Cimşit G, Yaylı S, Alpay K. Erythema dyschromicum perstans: response to dapsone therapy. Int J Dermatol 2004;43:220-222
  9. Ergin Ş, Erdoğan BŞ, Evliyaoğlu D, Bir F. An evaluation of dapsone therapy in two patients with erythema dyschromicum perstans (Eritema diskromikum perstans tanılı iki olguda dapsona yanıtın değerlendirilmesi). Fırat Tıp Dergisi 2007;12: 73-75
  10. Polat M, Yalçın B, Öztaş P, et al. Erythema Dyschromicum Perstans: report of five cases and review of the literature. Türkiye Klinikleri J Dermatol 2007;17:201-204
  11. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin 2000;18:91-98
  12. Vega ME, Waxtein L, Arenas R, Hojyo T, Dominguez- Soto L. Ashy dermatosis and lichen planus pigmentosus: a clinicopathologic study of 31 cases. Int J Dermatol 1992;31:90-94
  13. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol 2001;45:420-434.